BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/27/2022 1:17:37 PM | Browse: 616 | Download: 1642
 |
Received |
|
2022-02-23 22:26 |
|
Peer-Review Started |
|
2022-02-23 22:28 |
|
First Decision by Editorial Office Director |
|
2022-04-05 07:55 |
|
Return for Revision |
|
2022-04-05 13:07 |
|
Revised |
|
2022-04-19 21:20 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-06-15 02:57 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-06-16 18:04 |
|
Articles in Press |
|
2022-06-16 18:04 |
|
Edit the Manuscript by Language Editor |
|
2022-06-11 12:57 |
|
Typeset the Manuscript |
|
2022-07-01 04:01 |
|
Publish the Manuscript Online |
|
2022-07-27 13:17 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Efficacy and safety of COVID-19 vaccination in patients with cirrhosis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Vladimir Ivashkin, Albina Ismailova, Ksenia Dmitrieva, Roman Maslennikov, Maria Zharkova, Salehk Aliev, Vyacheslav Bakhitov and Vadim Marcinkevich |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Roman Maslennikov, MD, PhD, Assistant Professor, Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Pogodinskaya 1-1, Moscow 119435, Russia. mmmm00@yandex.ru |
| Key Words |
Coronavirus; Vaccination; Revaccination; Booster; SARS-CoV-2; Sputnik V |
| Core Tip |
The aim of the study was to evaluate the clinical efficacy and safety of vaccination against novel coronavirus disease 2019 (COVID-19) in patients with cirrhosis. No severe cases of COVID-19 were revealed in the vaccinated group. The vaccine efficacy was 69.5% (95% confidence interval [CI]: 18.5%-94.4%) against symptomatic cases of COVID-19, 100% (95%CI: 25.1%-100.0%) against severe cases, and 100% (95%CI: 1.6%-100.0%) against death associated with COVID-19. There was no significant difference in liver-related mortality, or the incidence of liver decompensation, bleeding esophageal varices, and vascular events between the two groups of patients. Vaccination against COVID-19 in patients with cirrhosis is effective and safe. |
| Publish Date |
2022-07-27 13:17 |
| Citation |
Ivashkin V, Ismailova A, Dmitrieva K, Maslennikov R, Zharkova M, Aliev S, Bakhitov V, Marcinkevich V. Efficacy and safety of COVID-19 vaccination in patients with cirrhosis. World J Hepatol 2022; 14(7): 1470-1479 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i7/1470.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i7.1470 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
